Centre For Cellular And Molecular Platforms Profile
Key Indicators
- Authorised Capital ₹ 1.00 K
as on 24-10-2024
- Paid Up Capital ₹ 1.00 K
as on 24-10-2024
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 7.44%
(FY 2023)
- Profit 8.65%
(FY 2023)
- Ebitda 72.43%
(FY 2023)
- Net Worth 9.68%
(FY 2023)
- Total Assets 8.77%
(FY 2023)
About Centre For Cellular And Molecular Platforms
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 K and a paid-up capital of Rs 1.00 K , as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Centre For Cellular And Molecular Platforms India is Taslimarif Saiyed as CEO. Shrikumar Suryanarayan, Satyajit Mayor, Manoj Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U73200KA2010NPL052117
- Company No.
052117
- Company Classification
Private Not For Profit Company
- Incorporation Date
08 Jan 2010
- Date of AGM
21 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Centre For Cellular And Molecular Platforms?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Taslimarif Saiyed  | CEO | 21-Apr-2017 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subramanian Ramaswamy | Director | 19-Mar-2010 | Current |
| Manoj Kumar | Director | 20-Sep-2019 | Current |
| Shrikumar Suryanarayan | Director | 19-Mar-2010 | Current |
| Satyajit Mayor | Director | 08-Jan-2010 | Current |
| Taslimarif Saiyed | Director and Ceo | 04-Apr-2017 | Current |
Financial Performance and Corporate Structure Insights of Centre For Cellular And Molecular Platforms.
Centre For Cellular And Molecular Platforms, for the financial year ended 2023, experienced modest growth in revenue, with a 7.44% increase. The company also saw a slight improvement in profitability, with a 8.65% increase in profit. The company's net worth moved up by a moderate rise of 9.68%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Centre For Cellular And Molecular Platforms?
In 2023, Centre For Cellular And Molecular Platforms had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Escape Velocity Accelerator India Private LimitedActive 10 years 10 monthsShrikumar Suryanarayan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Centre For Cellular And Molecular Platforms?
Unlock and access historical data on people associated with Centre For Cellular And Molecular Platforms, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Centre For Cellular And Molecular Platforms, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centre For Cellular And Molecular Platforms's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
